ITM Power Plc Hugely significant announcement

ITM Power Plc (LON:ITM) is the topic of discussion when Zeus Capital Research Director Tom McColm caught up with DirectorsTalk to talk about the first hydrogen station to be situated on the UK’s busiest refuelling station. Tom talks us through the news, his thoughts on the future of transport, why he thinks Tesla Inc (LON:TSLA) […]

See More...

Allergy Therapeutics Plc Acarovac Sales could top $500m

Allergy Therapeutics Plc (LON:AGY) is the topic of conversation with Dr Gary Waanders Director of Healthcare Research at Zeus Capital. Since Allergy Therapeutics announced today that it has obtained approval to begin a phase I clinical trial of its Acarovac MPL vaccine in Spain, Gary explains what the product designed to do, what CTA clearance […]

See More...

Oncimmune Holdings Plc Sales growth to come from a number of directions

Oncimmune Holdings Plc (LON:ONC) is the topic of conversation when Dr Gary Waanders the Director of Healthcare Research at Zeus Capital caught up with DirectorsTalk. Gary talks us through the latest interim results, the company’s key strengths and explains what is going to drive top line growth in the next 2-3 years. Gary is an […]

See More...